News: Sequenom Inc (SQNM.OQ)
SQNM.OQ on NASDAQ Stock Exchange Global Select Market
4.22USD
19 Jun 2013
4.22USD
19 Jun 2013
Price Change (% chg)
$0.03 (+0.72%)
$0.03 (+0.72%)
Prev Close
$4.19
$4.19
Open
$4.19
$4.19
Day's High
$4.36
$4.36
Day's Low
$4.19
$4.19
Volume
349,128
349,128
Avg. Vol
506,112
506,112
52-wk High
$5.36
$5.36
52-wk Low
$2.65
$2.65
Select another date:
Select another date:
- Here's What This $4 Billion Winning Hedge Fund Company Has Bought and Sold
- Sequenom: Deciphering The Business Model
- As The Patent Cliff Approaches, Buy Trovagene
- Sequenom: Disruptive Innovation Is Driving Investment In NIPT
- Sequenom: Plenty Of Room To Run
- 6 Ways You Can Profit From Molecular Diagnostics
Press Releases
- Sequenom Provides Update On Status Of Patent For Methods Of Detecting Fetal Aneuploidy
- Sequenom Announces Leadership Appointments
- Sequenom, Inc. Announces Issuance Of Patent For Methods Of Detecting Fetal Aneuploidy
- Sequenom Announces Participation at Oppenheimer 23rd Annual Healthcare Conference
- The American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee Recommend Noninvasive Prenatal Testing for Fetal Aneuploidy
- Study Shows Sequenom CMM's RetnaGene LDT Accurately Predicts Risk of Progression to Wet Form of AMD
- Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2012 And Announces 90,000 Annualized Run Rate For MaterniT21™ PLUS Tests
- Technical Analysis on Sequenom Inc. and Biogen Idec Inc. - Biotech Momentum Slowing
- Sequenom Announces Participation At Two Upcoming Investor Conferences
- California Technology Assessment Forum Recommends Use Of Cell-Free DNA Technology As Advanced Prenatal Testing For Pregnant Women At High Risk For Fetal Chromosomal Anomalies

